Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Ginseng
Selected research topic
Blood pressure and vascular health
Some measured outcomes improved in human comparison studies. Read these findings with their populations and conditions.
- Publications for this topic
- 4
- Human comparison publications
- 2
- Publications needing review
- 1
Findings in the studies
augmentation index
- A better result than the comparison group was reported.General population · Single ingredient · 3 hours after intervention
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · General population
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups. · Study comparison: Rg3-Korean red ginseng extract versus wheat-bran control.
- Additional measurement information
- Secondary outcome
- Measurement time
- 3 hours after intervention
brachial systolic
- A better result than the comparison group was reported.General population · Single ingredient · 3 hours after intervention
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · General population
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups. · Study comparison: Rg3-Korean red ginseng extract versus wheat-bran control.
- Additional measurement information
- Secondary outcome
- Measurement time
- 3 hours after intervention
central systolic
- A better result than the comparison group was reported.General population · Single ingredient · 3 hours after intervention
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · General population
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups. · Study comparison: Rg3-Korean red ginseng extract versus wheat-bran control.
- Additional measurement information
- Secondary outcome
- Measurement time
- 3 hours after intervention
Diastolic blood pressure
- A better result than the comparison group was reported.
What the comparison group used was not confirmed.
Single ingredientMeasurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · Participant characteristics were not confirmed.
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups.
- Measurement time
- Not confirmed.
Other measured outcomes (2)
diastolic BP
- A better result than the comparison group was reported.General population · Single ingredient · 3 hours after intervention
Measurement and study conditions
- Study type
- Randomized controlled trial: subjects were randomly assigned to groups for comparison.
- Study population
- Human participants · General population
- Ingredients tested
- Single ingredient
- How results were compared
- Results were compared between groups. · Study comparison: Rg3-Korean red ginseng extract versus wheat-bran control.
- Additional measurement information
- Secondary outcome
- Measurement time
- 3 hours after intervention
Outcome needs clarification
About this measure
Original outcome name: FMD
Research with unclear study subject or type
- A change was reported, but the comparison could not be confirmed.Single ingredient
Measurement and study conditions
- Study type
- Meta-analysis
- Study population
- Recorded population category: General population. Whether the research involved humans needs confirmation.
- Ingredients tested
- Single ingredient
- How results were compared
- Study comparison: Pooled ginseng effects on flow-mediated dilation in clinical trials
- Additional measurement information
- Biomarker
- Measurement time
- Not confirmed.
Representative outcome and study details
Human studies reported between-group improvement in augmentation index.
Single-ingredient studies · Human studies · between-group comparison
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 37.7 evidence score includes 2 independent human studies and 2 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, limited repeated evidence for directly felt outcomes.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 91
Papers linked to this topic 4 · distinct papers 4 · papers with a confirmed human comparison 2 · papers needing additional review 1
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- augmentation index: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- brachial systolic: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- central systolic: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- Diastolic blood pressure: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- diastolic BP: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- FMD: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
augmentation index
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · General population
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
brachial systolic
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · General population
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
central systolic
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · General population
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Diastolic blood pressure
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · Unspecified population
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
diastolic BP
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · General population
Between-group comparison
Analysis coverage and paper counts
1 paper · 2 measured outcomes
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
FMD
A change was reported, but the comparison could not be confirmed.
Meta-analysis · Single ingredient · General population
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Controlled study in people · Single ingredient · Unspecified population
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 1 combination findings and 0 findings that outperformed an ingredient alone.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
비타민 EThe combined supplement significantly improved the desire domain of the FSFI compared to placebo.